Who has invested in Oncopeptides?

Artisan Partners, Bain Capital Public Equity, LP, HealthCor Management are named among the investors backing Oncopeptides.

Oncopeptides Funding: $130M Raised, Investors & Rounds

Oncopeptides funding overview

Oncopeptides is based in Stockholm, Sweden. Oncopeptides has raised $130M in total disclosed funding. That places its disclosed total in the $100M–$250M range. The round record for Oncopeptides runs through 2021; nothing later has been disclosed. Investors on record include Artisan Partners, Bain Capital Public Equity, LP, HealthCor Management. 3 distinct backers are named across the disclosed rounds.

Oncopeptides at a glance

Total raised: $130M
Latest round date: March 2021
Headquarters: Stockholm, Sweden
Notable investors: Artisan Partners, Bain Capital Public Equity, LP, HealthCor Management

Frequently asked about Oncopeptides funding

How much has Oncopeptides raised?: Oncopeptides has raised $130M in total disclosed funding across the rounds on record.
Who has invested in Oncopeptides?: Artisan Partners, Bain Capital Public Equity, LP, HealthCor Management are named among the investors backing Oncopeptides.
What was the latest Oncopeptides funding round?: No round stage has been disclosed for Oncopeptides.
Where is Oncopeptides based?: Oncopeptides is based in Stockholm, Sweden.
When did Oncopeptides last raise?: The last disclosed Oncopeptides round closed in March 2021.

Oncopeptides totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Stockholm below to benchmark round size and investor mix.

Oncopeptides Funding: $130M Raised, Investors & Rounds

Oncopeptides funding overview

Oncopeptides at a glance

Frequently asked about Oncopeptides funding

Companies related to Oncopeptides (18)

Browse related funding lists (2)